News Detail
Bengaluru, 14 Sept 2023: Karnataka drugs controller BT Khanapure has stated that his department will immediately start investigations into the pricing violations of the anti-cancer drugs highlighted by the Bangalore District Chemists & Druggists Association and Suvarna Karnat......
View Details
Source : Pharmabiz
BT Khanapure
pricing violations
anti-cancer
Bangalore District Chemists & Druggists Association
Suvarna Karnataka Chemists & Druggists Association
Rituximab
BDCDA
SKCDA
Maball
YouTube
India Pharma Channel
NLEM
Nfiera
Zydus Celexa
Related News
- AIIMS forms special committee to monitor adverse drug reactions (19-03-2025)
- Ayush-approved medicines won't require extra safety trials for integrative research: ICMR (19-03-2025)
- USV launches Xenia: Empagliflozin and its combinations for diabetes care in India (19-03-2025)
- Experts Call for Unified Action Against Counterfeiting in Supply Chains (19-03-2025)
- FMCG firms seek separate law for beauty products, current regulations hinder growth (18-03-2025)
- Mumbai: Court rejects discharge pleas of docs booked for prescribing ‘miracle drug’ of Munir Khan (18-03-2025)
- Raid on a factory making fake Moov and Veet creams, stock seized (18-03-2025)
- 616 bottles of codeine-containing cough syrup seized, 2 arrested (18-03-2025)
- Hair growth medicine damages eyesight! 'miracle camp' resulted in hospitalization (18-03-2025)
- Unlicensed Pakistani Cosmetics Seized in Pimpri-Chinchwad; legal actions set to be initiated before legislative session wraps up (18-03-2025)